Cartesian Therapeutics Stock (NASDAQ: RNAC) stock price, news, charts, stock research, profile.
You can purchase shares of Cartesian Therapeutics (NASDAQ:RNAC) through any online brokerage.
Other companies in Cartesian Therapeutics’s space includes: KalVista Pharma (NASDAQ:KALV), 4D Molecular Therapeutics (NASDAQ:FDMT), Valneva (NASDAQ:VALN), Voyager Therapeutics (NASDAQ:VYGR) and Altimmune (NASDAQ:ALT).
Cartesian Therapeutics has a consensus price target of $40.80.
The stock price for Cartesian Therapeutics (NASDAQ: RNAC) is $17.77 last updated November 12, 2024 at 4:10 PM EST.
There are no upcoming dividends for Cartesian Therapeutics.
Cartesian Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Cartesian Therapeutics.
Cartesian Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.